Recognition and simultaneous determination of ofloxacin enantiomers by synchronization - 1st derivative fluorescence spectroscopy

被引:46
作者
Gong, QJ
Qiao, JL
Du, LM
Dong, C
Jin, WJ [1 ]
机构
[1] Shanxi Univ, Dept Chem, Taiyuan 030006, Peoples R China
[2] Yuncheng Adv Training Coll, Yuncheng 04000, Shanxi, Peoples R China
[3] Taiyuan Univ Technol, Dept Chem, Coll Arts & Sci, Taiyuan 030024, Peoples R China
[4] Shanxi Teachers Univ, Anal & Test Ctr, Shanxi, Peoples R China
基金
中国国家自然科学基金;
关键词
ofloxacin; enantiomer; synchronization-derivative fluorescence spectroscopy; urine sample; recognition; determination;
D O I
10.1016/S0039-9140(00)00503-8
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Under controlling pH 3, R-(+)- and S-(-)-ofloxacin (OFLX) enantiomers can be well recognized and resolved by the synchronization-ist derivative fluorescence spectroscopic techniques, and the interference from urine blank also can be eliminated. The linear dynamic ranges are 0.36-2.16 (R), 0.36-2.89 and 3.16-31.6 mug/ml (S), respectively, for determining OFLX in urine samples. The limits of detection are 0.36 mug/ml (R) and the recoveries of R-(+)- and S-(-)-OFLX in urine samples are 97-104%. Relative standard deviation is < 6.6%. Pharmacokinetic study of OFLX and levofloxacin shows that R-(+)- and S-(-)-ofloxacin reach their peak concentration in urine samples after a healthy subject has taken tablets for <similar to> 3 and 6 h, respectively. R-(+)-OFLX can be obviously detected in 5-6 h after a healthy subject has taken tablets, indicating the transformation of S-(-)- to R-( +)-OFLX enantiomer in human body (in vitro). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 10 条
[1]   DETERMINATION OF OFLOXACIN, A NEW OXAZINE DERIVATIVE IN HUMAN-SERUM, URINE, AND BILE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
CARLUCCI, G ;
GUADAGNI, S ;
PALUMBO, G .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1986, 9 (11) :2539-2547
[2]  
CHUAN LJ, 1997, FENXI ZAZHI, V50, P295
[3]   INVITRO ANTIBACTERIAL ACTIVITY OF DR-3355, THE S-(-)-ISOMER OF OFLOXACIN [J].
FUJIMOTO, T ;
MITSUHASHI, S .
CHEMOTHERAPY, 1990, 36 (04) :268-276
[4]  
HARTMUT GH, 1987, ANTIMICROB AGENTS CH, V8, P1338
[5]  
HONG WW, 1996, YAOWU FENXI, V16, P30
[6]  
HOOPER DC, 1991, NEW ENGL J MED, V324, P384, DOI 10.1056/NEJM199102073240606
[7]   THE PHARMACOKINETICS AND TISSUE PENETRATION OF OFLOXACIN [J].
LOCKLEY, MR ;
WISE, R ;
DENT, J .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1984, 14 (06) :647-652
[8]   DETERMINATION OF OFLOXACIN IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH COLUMN SWITCHING [J].
OHKUBO, T ;
KUDO, M ;
SUGAWARA, K .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1992, 573 (02) :289-293
[9]  
QI Y, 1997, YAOXUE XUEBAO, V32, P203
[10]  
SU C, 1994, YAOXUE XUEBAO, V29, P223